C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 311/36 (2006.01) A61K 31/353 (2006.01) A61P 25/32 (2006.01) C07D 405/04 (2006.01) C07D 405/14 (2006.01) C07D 413/12 (2006.01) C07D 413/14 (2006.01) C07D 417/12 (2006.01)
Patent
CA 2712750
Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.
La présente invention concerne de nouveaux dérivés d'isoflavone, dont la structure est représentée par la formule (I), qui se révèlent utiles en tant qu'inhibiteurs d'ALDH-2 pour traiter des mammifères qui dépendent de substances créant un effet d'accoutumance, par exemple l'accoutumance à un agent produisant de la dopamine tel que la cocaïne, la morphine, les amphétamines, la nicotine et l'alcool.
Abelman Matthew
Arolfo Maria Pia
Bilokin Yaroslav
Diamond Ivan
Elzein Elfatih
Gilead Palo Alto Inc.
Smart & Biggar
The Endowment For Research In Human Biology Inc.
LandOfFree
Aldh-2 inhibitors in the treatment of addiction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aldh-2 inhibitors in the treatment of addiction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aldh-2 inhibitors in the treatment of addiction will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2011931